Company attributes
Venture Capital Firm attributes
Other attributes
HBM Healthcare Investments AG, also known as HBM BioVentures, is a venture capital and private equity firm investing in medicine, biotechnology, medical technology, and diagnostics companies that is headquartered in Zug, Switzerland. The firm is listed on SIX Swiss Exchange (HBMN).
HBM Healthcare Investments AG prefers to invest in later-stage private companies that require financing for growing their company in Europe, Asia, and North America. Notable investments made by HBM Healthcare Investments AG include: Arcutis Biotherapeutics, 1mg, Viela Bio, Adrenomed, Galecto Biotech, Turning Point Therapeutics, CardiaLen, 4TEEN4 Pharmaceuticals, Galera Therapeutics, Jianke, PTC Therapeutics, AnaptysBio, Advanced Accelerator Applications, IVERIC Bio, Homology Medicines, ARMO BioSciences, and Aptinyx.
